FNCHQ

Finch Therapeutics Group, Inc.

CIK 0001733257 · OTC

OTCHealth CareBiological Products, (No Diagnostic Substances)

$10.55

↑ 0.03 (0.29%)

as of Jul 9, 2026

End-of-day close, not real-time intraday

Overall read: NeutralOverall score · based on 3/4 lenses

FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap

$16.94M

P/E Ratio

-1.35

EPS

-46.59

Dividend Yield

Not covered

52W Position

61%

Beta

-0.05

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

1.19

P/S

Not covered

EV/Revenue

Not covered

ROE

-88.4%

Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 61%

$2.00$16.10

Latest Financials

2023-12-31 FY

Revenue

$107.00K

Net Income

-$74.75M

Total Assets

$55.37M

Free Cash Flow

-$31.50M

FNCHQ

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

FNCHQ

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news